+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
ID07391982

Study Comparing Lower Radiation Dose to Healthy Prostate Tissue Versus Uniform High Dose Using MR-Linac in Men With Low to Intermediate-Risk Prostate Cancer

Led by The Netherlands Cancer Institute · Updated on 2026-02-06

54

Participants Needed

1

Research Sites

95 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating ways to reduce side effects from radiation treatment for men with low or intermediate-risk prostate cancer. The study aims to see if lowering the radiation dose to healthy parts of the prostate, while keeping a high dose for visible tumors detected by MRI, can reduce bowel and urinary side effects without losing effective cancer control. This clinical trial is sponsored by The Netherlands Cancer Institute and focuses on improving quality of life during prostate cancer treatment. The study compares two approaches one group receives a uniform high radiation dose to the entire prostate, while the other group receives a lower dose to healthy prostate tissue and a higher dose only to the MRI-visible tumor areas. Treatments use an MR-Linac machine to deliver two sessions of MRI-guided radiotherapy. The lower dose area includes the benign prostate with 20 Gy in 2 fractions, and the tumor areas receive 27 Gy in 2 fractions, with specific margins applied for precision. Participants will complete questionnaires about urinary, bowel, and sexual health before and after treatment. Follow-up visits will monitor side effects, PSA levels, and quality of life for up to 2 years. Researchers will measure acute and late urinary and bowel side effects, erectile dysfunction severity, biochemical relapse-free survival, and overall health-related quality of life. The primary outcome focuses on acute urinary toxicity within 13 weeks of starting radiotherapy.

CONDITIONS

Brief Title

Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions

Research Team

F

Floris Pos, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here